fla 797 has been researched along with remoxipride in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeby-Möller, K; de Paulis, T; Florvall, L; Hall, H; Johansson, L; Kumar, Y; Ogren, SO; Rämsby, S | 1 |
| Hollingsworth, EB; Kelley, JL; Norman, MH | 1 |
| Dorostkar, F; Fatemi, MH | 1 |
| Brinkman, UA; Das, HA; Frei, RW; Veltkamp, AC | 1 |
| Csöregh, I; de Paulis, T; Högberg, T; Rämsby, S; Stensland, B; Wägner, A | 1 |
| Andersson, I; Gustafsson, K; Westlind-Danielsson, A | 1 |
| Lundström, J; Nilsson, LB; Ogren, SO | 1 |
| Lundström, J; Nilsson, LB; Ogren, SO; Widman, M | 1 |
8 other study(ies) available for fla 797 and remoxipride
| Article | Year |
|---|---|
Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides.
Topics: Animals; Apomorphine; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine Antagonists; Humans; Hyperkinesis; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Inbred Strains; Salicylamides; Spiperone; Stereotyped Behavior; Structure-Activity Relationship | 1985 |
Conformationally restricted analogues of remoxipride as potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Benzamides; Drug Evaluation, Preclinical; Male; Molecular Conformation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Remoxipride; Structure-Activity Relationship | 1993 |
QSAR prediction of D2 receptor antagonistic activity of 6-methoxy benzamides.
Topics: Benzamides; Dopamine D2 Receptor Antagonists; Models, Molecular; Quantitative Structure-Activity Relationship | 2010 |
On-line low-level radiometric detection of [14C]remoxipride in liquid chromatographic effluents. Application to urine samples.
Topics: Antipsychotic Agents; Benzamides; Chromatography, Liquid; Humans; Remoxipride; Salicylamides; Sodium Hydroxide; Spectrophotometry, Ultraviolet | 1987 |
Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor models.
Topics: Benzamides; Models, Molecular; Molecular Conformation; Receptors, Dopamine; Remoxipride; Salicylamides; Software; Structure-Activity Relationship; X-Ray Diffraction | 1986 |
Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Calcium; Colforsin; Corpus Striatum; Cyclic AMP; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; In Vitro Techniques; Male; Pergolide; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Remoxipride; Salicylamides; Structure-Activity Relationship; Sulpiride | 1994 |
Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile.
Topics: Animals; Basal Ganglia Diseases; Brain; Catalepsy; Chromatography, High Pressure Liquid; Circadian Rhythm; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Male; Rats; Rats, Sprague-Dawley; Remoxipride; Salicylamides; Spectrophotometry, Ultraviolet | 1993 |
Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.
Topics: Animals; Body Temperature; Chromatography, High Pressure Liquid; Dopamine D2 Receptor Antagonists; Ergolines; Haloperidol; Hypothermia; Male; Pergolide; Quinpirole; Rats; Rats, Sprague-Dawley; Remoxipride; Salicylamides | 1993 |